With the COVID emergency officially declared over, health officials are tallying up the numbers that reflect the pandemic’s legacy. One glaring number they’re shaking their heads at is the report that only an abysmal 17% of Americans have received the latest booster of the experimental COVID gene therapy shot.

One reason is because, the public has lost interest in the COVID shots, CNBC reported, and that’s a concern because “the virus will remain a persistent threat to the elderly, the vulnerable and the nation’s fragmented, battered health-care system.”

Warning that immunity “doesn’t last,” Dr. James Lawler, infectious disease expert at the University of Nebraska Medical Center, urged people to get up to date on their shots.  

SOURCE:

CNBC May 11, 2023